BIOLOGY OF MALARIA SPOROZOITES IN THE MOSQUITO VECTOR
蚊子媒介中疟疾孢子的生物学
基本信息
- 批准号:6193241
- 负责人:
- 金额:$ 36.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-06-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:Aedes Plasmodium berghei SDS polyacrylamide gel electrophoresis cellular pathology chickens communicable disease control communicable disease transmission confocal scanning microscopy disease vectors green fluorescent proteins hamsters high performance liquid chromatography host organism interaction intracellular parasitism laboratory rabbit life cycle malaria molecular cloning molecular pathology monoclonal antibody polymerase chain reaction receptor binding salivary glands spores western blottings
项目摘要
The long-term goal of the proposed research is to understand malaria sporozoite passage through the mosquito hemocoel and invasion of the salivary glands, which are required for parasite transmission to a new host. This period remains a little-studied but critical interval of the malaria life cycle. Disrupting the essential receptor-ligand binding necessary for gland invasion may be a new approach for vector-based control of malaria transmission. The specific aims are to: 1) Molecularly characterize candidate salivary gland receptors for sporozoite invasion. We have 25 hybridoma lines that produce monoclonal antibodies (mAbs) specific for molecules on the surface of Aedes aegypti salivary glands. Several mAbs inhibit Plasmodium gallinaceum sporozoite invasion into glands, and thus are candidate receptors. We will identify the molecules identified by the gland-specific mAbs, clone their cognate cDNAs, and raise polyclonal antibodies against recombinant protein. 2) Test the biological function of candidate sporozoite receptors by an in vivo assay for invasion blocking. Purified sporozoites will be inoculated into the hemocoel of uninfected mosquitoes, along with polyclonal antibodies directed against candidate receptors. The inhibition of sporozoite invasion by specific antibodies relative to controls will identify presumptive receptor molecules that are necessary for sporozoite invasion to occur. 3) Determine the fate of non-invaded sporozoites in the mosquito hemocoel. Our preliminary results indicate that sporozoites that do not invade the salivary glands, are probably destroyed in the hemocoel. Identifying the site of sporozoite destruction is a first step to understanding the cellular and molecular basis of a potential specific immune response and exploiting it in malaria transmission control. We have made a line of Plasmodium berghei genetically transformed to produce fluorescent sporozoites. We will infect Anopheles gambiae with these parasites and will then track and quantify the fluorescent sporozoites in the mosquitoes by confocal microscopy to identify the sites and cellular mechanism of sporozoite destruction. Overall, we propose that there is a competition in the hemocoel between the processes of sporozoite destruction and gland invasion. By blocking gland invasion and/or enhancing destruction, it may ultimately be possible to manipulate this dynamic state to decrease natural malaria transmission.
拟议研究的长期目标是了解疟疾子孢子通过蚊子血腔和唾液腺的入侵,这是寄生虫传播到新宿主所必需的。 这一时期仍然是疟疾生命周期中一个很少研究但至关重要的时期。 破坏腺体侵入所必需的基本受体-配体结合可能是一种基于病媒控制疟疾传播的新方法。 具体目标是:1)分子表征子孢子入侵的候选唾液腺受体。 我们有25个杂交瘤细胞系,产生的单克隆抗体(单克隆抗体)的分子上的埃及伊蚊唾液腺的表面。 几种单克隆抗体抑制鸡疟原虫子孢子侵入腺体,因此是候选受体。 我们将鉴定腺特异性单克隆抗体所识别的分子,克隆其同源cDNA,并针对重组蛋白产生多克隆抗体。 2)通过体内侵袭阻断试验测试候选子孢子受体的生物学功能。 将纯化的子孢子与针对候选受体的多克隆抗体一起沿着接种到未感染蚊子的血腔中。 相对于对照,特异性抗体对子孢子侵入的抑制将鉴定子孢子侵入发生所必需的假定受体分子。 3)确定蚊子血腔中未侵入子孢子的命运。 我们的初步结果表明,不侵入唾液腺的子孢子可能在血腔中被破坏。确定子孢子破坏位点是了解潜在特异性免疫应答的细胞和分子基础并将其用于疟疾传播控制的第一步。 我们已经建立了一个基因转化的伯氏疟原虫生产荧光子孢子。 我们将这些寄生虫感染冈比亚按蚊,然后通过共聚焦显微镜跟踪和定量蚊子体内的荧光子孢子,以确定子孢子破坏的部位和细胞机制。 总的来说,我们提出,有一个竞争的子孢子破坏和腺体入侵的过程之间的血腔。 通过阻止腺体侵入和/或增强破坏,最终可能操纵这种动态状态以减少疟疾的自然传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH D VERNICK其他文献
KENNETH D VERNICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH D VERNICK', 18)}}的其他基金
Genetic Association Mapping of Malaria Resistance in Anopheles gambiae
冈比亚按蚊疟疾抗性的遗传关联图谱
- 批准号:
7245415 - 财政年份:2007
- 资助金额:
$ 36.87万 - 项目类别:
Genetic Association Mapping of Malaria Resistance in Anopheles gambiae
冈比亚按蚊疟疾抗性的遗传关联图谱
- 批准号:
7418205 - 财政年份:2007
- 资助金额:
$ 36.87万 - 项目类别:
Genetic Association Mapping of Malaria Resistance in Anopheles gambiae
冈比亚按蚊疟疾抗性的遗传关联图谱
- 批准号:
8054930 - 财政年份:2007
- 资助金额:
$ 36.87万 - 项目类别:
Genetic Association Mapping of Malaria Resistance in Anopheles gambiae
冈比亚按蚊疟疾抗性的遗传关联图谱
- 批准号:
7618755 - 财政年份:2007
- 资助金额:
$ 36.87万 - 项目类别:
Genetic Association Mapping of Malaria Resistance in Anopheles gambiae
冈比亚按蚊疟疾抗性的遗传关联图谱
- 批准号:
7799322 - 财政年份:2007
- 资助金额:
$ 36.87万 - 项目类别:
Proteomics of mosquito immune response to malaria
蚊子对疟疾免疫反应的蛋白质组学
- 批准号:
6571465 - 财政年份:2002
- 资助金额:
$ 36.87万 - 项目类别:
Proteomics of mosquito immune response to malaria
蚊子对疟疾免疫反应的蛋白质组学
- 批准号:
6661950 - 财政年份:2002
- 资助金额:
$ 36.87万 - 项目类别:
Proteomics of mosquito immune response to malaria
蚊子对疟疾免疫反应的蛋白质组学
- 批准号:
6794932 - 财政年份:2002
- 资助金额:
$ 36.87万 - 项目类别:
BIOLOGY OF MALARIA SPOROZOITES IN THE MOSQUITO VECTOR
蚊子媒介中疟疾孢子的生物学
- 批准号:
6511089 - 财政年份:2000
- 资助金额:
$ 36.87万 - 项目类别:
BIOLOGY OF MALARIA SPOROZOITES IN THE MOSQUITO VECTOR
蚊子媒介中疟疾孢子的生物学
- 批准号:
6752040 - 财政年份:2000
- 资助金额:
$ 36.87万 - 项目类别:
相似海外基金
Investigation of the molecular mechanism of RON4 in Plasmodium berghei sporozoite infection of mammalian hosts
RON4在伯氏疟原虫子孢子感染哺乳动物宿主中的分子机制研究
- 批准号:
20K16235 - 财政年份:2020
- 资助金额:
$ 36.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IFNGR1 in pregnant mice infected with Plasmodium berghei
IFNGR1 在感染伯氏疟原虫的怀孕小鼠中的作用
- 批准号:
15K08451 - 财政年份:2015
- 资助金额:
$ 36.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of experimental cerebral malaria by activation of nonlethal malaria parasite-specific CD4+T cells via MHC class II in mice coinfected with Plasmodium berghei ANKA and nonlethal Pb XAT
在伯氏疟原虫 ANKA 和非致命性 Pb XAT 共感染的小鼠中,通过 MHC II 类激活非致命性疟疾寄生虫特异性 CD4 T 细胞来抑制实验性脑型疟疾
- 批准号:
24790405 - 财政年份:2012
- 资助金额:
$ 36.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The suppression of severe pathology during coinfection with Plasmodium berghei ANKA and Plasmodium berghei XAT
伯氏疟原虫 ANKA 和伯氏疟原虫 XAT 共感染期间严重病理的抑制
- 批准号:
21790410 - 财政年份:2009
- 资助金额:
$ 36.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The impact of multiple stresses including infection with Plasmodium berghei on mosquito behaviour
包括伯氏疟原虫感染在内的多种应激对蚊子行为的影响
- 批准号:
303583-2005 - 财政年份:2005
- 资助金额:
$ 36.87万 - 项目类别:
Postgraduate Scholarships - Master's
Wechselseitige Beeinflussung der Infektionsverläufe von muriner Malaria und Nematodeninfektion am Beispiel der Co-Infektion von Plasmodium berghei mit Litomosoides sigmodontis bzw. Nippostrongylus brasiliensis
以伯氏疟原虫与乙状疟原虫和巴西圆线虫共同感染为例探讨鼠疟疾和线虫感染过程的相互影响
- 批准号:
5423379 - 财政年份:2004
- 资助金额:
$ 36.87万 - 项目类别:
Research Grants
Comparison of the Plasmodium berghei Multi-drug Resistance Associated Protein (
伯氏疟原虫多重耐药相关蛋白的比较(
- 批准号:
6980095 - 财政年份:2004
- 资助金额:
$ 36.87万 - 项目类别:
Survival strategies of Plasmodium berghei exoerythrocytic forms (EEF) in hepatocytes
伯氏疟原虫红细胞外型(EEF)在肝细胞中的生存策略
- 批准号:
5435108 - 财政年份:2004
- 资助金额:
$ 36.87万 - 项目类别:
Priority Programmes
The impact of multiple stresses including infection with Plasmodium berghei on mosquito behaviour
包括伯氏疟原虫感染在内的多种应激对蚊子行为的影响
- 批准号:
303583-2004 - 财政年份:2004
- 资助金额:
$ 36.87万 - 项目类别:
Postgraduate Scholarships - Master's
Characterization of newly defined protective antigens of Plasmodium berghei XAT.
新定义的伯氏疟原虫 XAT 保护性抗原的表征。
- 批准号:
14570219 - 财政年份:2002
- 资助金额:
$ 36.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)